Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “labelling”
Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution
ClinicalTrials.gov study NCT01958619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multiple SC Doses of Drisapersen in Patients With Duchenne Muscular Dystrophy and to Assess the
ClinicalTrials.gov study NCT01910649. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Impacts of Warning Labels on Ultra-Processed Foods
ClinicalTrials.gov study NCT06296355. IPD Sharing: YES. Countries: 1. Publications: 0.
Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
ClinicalTrials.gov study NCT00174382. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor Fluctuations
ClinicalTrials.gov study NCT03877510. IPD Sharing: NO. Countries: 8. Publications: 0.
A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years
ClinicalTrials.gov study NCT02269488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients
ClinicalTrials.gov study NCT01518309. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With t
ClinicalTrials.gov study NCT01726738. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients
ClinicalTrials.gov study NCT00002178. IPD Sharing: Not stated. Countries: 1. Publications: 1.
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for
ClinicalTrials.gov study NCT01575561. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)
ClinicalTrials.gov study NCT05996536. IPD Sharing: YES. Countries: 1. Publications: 0.
Open Label, Study Of Efficacy and Safety Of AVR-RD-01 for Treatment-Naive Subjects With Classic Fabry Disease
ClinicalTrials.gov study NCT03454893. IPD Sharing: NO. Countries: 3. Publications: 0.
Evaluation of Labeling Comprehension and Performance of a New Blood Glucose Meter System
ClinicalTrials.gov study NCT00804596. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
ClinicalTrials.gov study NCT01894022. IPD Sharing: Not stated. Countries: 16. Publications: 0.
PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain
ClinicalTrials.gov study NCT01719757. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.
ClinicalTrials.gov study NCT05827536. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Functionality, Safety and Efficacy Study in Patients Undergoing Elective Unilateral Knee Replacement
ClinicalTrials.gov study NCT00859313. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
ClinicalTrials.gov study NCT03686683. IPD Sharing: NO. Countries: 1. Publications: 0.
12-week Open-label Evaluation of Efficacy and Safety of Indacaterol
ClinicalTrials.gov study NCT01232894. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label Arm
ClinicalTrials.gov study NCT06587217. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.